[Adjuvant systemic therapy of breast carcinoma]

Med Klin (Munich). 1996 Oct 15;91(10):646-53.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / mortality
  • Breast Neoplasms / pathology
  • Chemotherapy, Adjuvant
  • Combined Modality Therapy
  • Female
  • Humans
  • Neoplasm Staging
  • Survival Rate
  • Treatment Failure

Substances

  • Antineoplastic Agents